Pooled analyses showed that oat β-glucan has a lowering effect on LDL-cholesterol , non-HDL-cholesterol and apoB. Inclusion of oat-containing foods may be a strategy for achieving targets in CVD reduction
Oats are a rich source of β-glucan , a viscous , soluble fibre recognised for its cholesterol-lowering properties , and are associated with reduced risk of CVD .
Our objective was to conduct a systematic review and meta- analysis of r and omised-controlled trials ( RCT ) investigating the cholesterol-lowering potential of oat β-glucan on LDL-cholesterol , non-HDL-cholesterol and apoB for the risk reduction of CVD .
Effect of oat bran on plasma cholesterol and bile acid excretion in nine subjects with ileostomies.
A higher excretion of dry matter , fat , nitrogen , energy , and total bile acids in ileal effluents ; a lower plasma low-density-lipoprotein ( LDL ) and total cholesterols ( 12.1 % and 9.0 % lower respectively ) ; but no change in plasma high-density-lipoprotein ( HDL ) cholesterol or apolipoproteins A-I and B were observed in nine subjects with ileostomies when they consumed an oat-bran , bread-based , high-fiber diet ( HFD ) as compared with a wheat-flour , bread-based , low-fiber diet ( LFD ) for 3 wk with a crossover design . Of the nine subjects only the subjects with a low daily excretion of bile acids had an elevated excretion of total bile acids during the HFD compared with the LFD . Total cholesterol , LDL cholesterol , and apolipoprotein B in plasma also decreased by 11.3 % , 15.3 % , and 10.7 % , respectively , after consumption of the HFD for 3 wk
Pooled analyses showed that oat β-glucan has a lowering effect on LDL-cholesterol , non-HDL-cholesterol and apoB. Inclusion of oat-containing foods may be a strategy for achieving targets in CVD reduction
Oats are a rich source of β-glucan , a viscous , soluble fibre recognised for its cholesterol-lowering properties , and are associated with reduced risk of CVD .
Our objective was to conduct a systematic review and meta- analysis of r and omised-controlled trials ( RCT ) investigating the cholesterol-lowering potential of oat β-glucan on LDL-cholesterol , non-HDL-cholesterol and apoB for the risk reduction of CVD .